GT Biopharma announces request for withdrawal of Form S-1 registration statement

GT Biopharma (GTBP) has filed a Request for Withdrawal with the U.S. Securities and Exchange Commission with respect to the withdrawal of the Company’s Registration Statement on Form S-1 that it filed with the SEC originally on December 23, 2024. The Registration Statement has not been declared effective by the SEC, and no securities have been sold in connection with the offering described in the Registration Statement.